Navigation Links
Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
Date:11/27/2007

LOUISVILLE, Ky., Nov. 27 /PRNewswire-FirstCall/ -- Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") said today that its Board of Directors declared a regular quarterly dividend of $0.475 per share, payable in cash on December 28, 2007, to stockholders of record on December 7, 2007. The dividend is the fourth quarterly installment of the Company's $1.90 per share 2007 annual dividend.

This fourth quarterly installment of the Company's 2007 annual dividend will be included in stockholders' 2007 taxable income for income tax purposes. More specific information about Ventas's dividends paid in 2007 can be found on its website at http://www.ventasreit.com/investors/dividend.asp.

Ventas, Inc. is a leading healthcare real estate investment trust. Its diverse portfolio of properties located in 43 states and two Canadian provinces includes seniors housing communities, skilled nursing facilities, hospitals and medical office and other properties. More information about Ventas can be found on its website at http://www.ventasreit.com.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding Ventas, Inc.'s ("Ventas" or the "Company") and its subsidiaries' expected future financial position, results of operations, cash flows, funds from operations, dividends and dividend plans, financing plans, business strategy, budgets, projected costs, capital expenditures, competitive positions, acquisitions, investment opportunities, merger integration, growth opportunities, expected lease income, continued qualification as a real estate investment trust ("REIT"), plans and objectives of management for future operations and statements that include words such as "anti
'/>"/>

SOURCE Ventas, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
2. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
3. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
4. Ventas Appoints Brush SVP - Senior Housing Development and Operations
5. Landauer, Inc. Declares Regular Cash Dividend
6. Weight Watchers Declares Quarterly Dividend
7. Abbott Declares 335th Consecutive Quarterly Dividend
8. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
9. Colgate Declares Regular Quarterly Dividends
10. Governor Rendell Declares Senior Smiles Day in Pennsylvania; Goal is to Improve Oral Hygiene for Senior Citizens
11. Mayors Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...e-FirstCall/ -- The Providence Service,Corporatio...Norris, the Company,s,Chief Operating Officer, ha...ors. Mr. Norris, appointment fills the vacancy le...inger and returns the board to six members. Mr.,...d. , Mr. Norris, age 41, has been with Prov...
(Date:11/21/2008)...ovel technique to combat cancer, study says, ,...lgian researchers have discovered that some cancer...and this might lead to new treatments that starve ...ate, all cells in the body need to produce energy....s that requires oxygen. Compared with normal cells...
(Date:11/21/2008)...rously Protect Investment And Restore Shareholder ...SNewswire/ -- Dr. Stephen Joffe, Craig Joffe, and ...dule 13D with the U.S. Securities and Exchange Com...ing ownership of 11.4% of LCA-Vision, Inc. (Nasdaq... laser vision correction centers in 33 states in t...
(Date:11/21/2008)...re-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE:...rwhelmingly approved the proposals submitted to th...rmaceuticals Industries Ltd. (Nasdaq: TEVA ). ,...ing support of the transaction by the Barr shareho...CEO. "We are pleased with the progress that we con...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...staurants and the flourishing livestock trade in B...ng the sale of beef and pork following an outbreak...tan government spokesperson said cases of the cont...pecies of cloven-hoofed animals were being reporte...
...ientists in the US have solved the structure of a ...ing that they say will help treat cardiac or neuro...r researchers at Brown University have solved the ...ein 97 (SAP97) found in abundance in the heart and...
...lignant mesothelioma is a very aggressive tumor wh...hich is increasing in frequency throughout the wor...of Malignant mesothelioma is exposure to asbestos,...40) is also found to be a causative agent for deve...
...udies in the past have shown that certain compound... growth of breast, prostate, colon and stomach can...bladder cancer. In a more recent study researchers... hindered the growth of bladder cancer cells in th...
Other Medicine News:Health News:Malignant Mesothelioma – A New Genetic Revelatio 2Health News:Malignant Mesothelioma – A New Genetic Revelatio 3
(Date:11/19/2008)...if., Nov. 19 Amgen,(Nas...Company, a subsidiary of,Takeda Pharmaceutical Co...nrollment in the Phase 3 MONET1 trial evaluating m... and carboplatin for the first-line treatment of,...en temporarily suspended,following a planned safe...
(Date:11/19/2008)...on Payment from Roche- , , MONTVALE, N.J., ...ticals Corp. (Nasdaq: MEMY ) today announced tha...e 2 trial of R3487/MEM 3454, its lead alpha-7 nico...sociated with schizophrenia (CIAS). The Company h...riggering a $5.0 million payment from its partner ...
(Date:11/18/2008)...ciation,s 2008 Faces of Influenza survey underscor...inst influenza; Mother and Gold Medalist Kristi Ya...ov. 18 While 78 percent of mothers...and potentially life-threatening disease that can ...milies will get vaccinated this season, according ...
(Date:11/12/2008)... 12 A new study being,p...ill help answer the,question, what causes Parkinso...in the medical research into,Parkinson,s disease i...die,in the first place. Answering this question ha...nearly identical types of brain cells that produce...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Interleukin Genetics Announces Conversion of 242 04 Million of Debt Into Common Stock 2307 1Interleukin Genetics Announces Conversion of 242 04 Million of Debt Into Common Stock 2307 2Interleukin Genetics Announces Conversion of 242 04 Million of Debt Into Common Stock 2307 3Jingle bells not merry for tone deaf individuals 1679 1Jingle bells not merry for tone deaf individuals 1679 2Jingle bells not merry for tone deaf individuals 1679 3Drug aimed at 2 bioterror agents blocks live viral infection Weill Cornell team reports 1676 1Drug aimed at 2 bioterror agents blocks live viral infection Weill Cornell team reports 1676 2Drug aimed at 2 bioterror agents blocks live viral infection Weill Cornell team reports 1676 3St Jude finds link between cellular defense processes showing how cancer cells survive 8556 1St Jude finds link between cellular defense processes showing how cancer cells survive 8556 2St Jude finds link between cellular defense processes showing how cancer cells survive 8556 3
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: